This HTML5 document contains 141 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n8http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q51076389
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel article científic 2014年學術文章 articol științific научни чланак мақолаи илмӣ naučni članak 2014年学术文章 2014年學術文章 bilimsel makale article scientifique научна статия artykuł naukowy 2014년 논문 scientific article published on 20 June 2014 artikull shkencor 2014 nî lūn-bûn บทความทางวิทยาศาสตร์ 2014年学术文章 artículu científicu επιστημονικό άρθρο artigo científico vetenskaplig artikel vitenskapelig artikkel bài báo khoa học wissenschaftlicher Artikel مقالة علمية نشرت في 20 يونيو 2014 2014年学术文章 articolo scientifico scienca artikolo 2014年學術文章 videnskabelig artikel scientific article published on 20 June 2014 artigo científico 2014年学术文章 tieteellinen artikkeli vitskapeleg artikkel სამეცნიერო სტატია vědecký článek מאמר מדעי 2014年學術文章 наукова стаття, опублікована в червні 2014 teaduslik artikkel artículo científico publicado en 2014 artikel ilmiah научни чланак 2014年学术文章 2014年學術文章 article scientific научная статья scientific article published on 20 June 2014 artikulong pang-agham 2014年の論文 2014年学术文章 vedecký článok artigo científico ২০ জুন ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ tudományos cikk
p:P577
wds:Q51076389-64C04CB0-8770-4CD1-8357-881D22104629
wdt:P577
2014-06-20T00:00:00Z
p:P2860
wds:Q51076389-3C70D981-6F59-4294-8D90-5F897F16605C wds:Q51076389-2EA0C522-9268-4C66-BCDE-270F8106B508 wds:Q51076389-2FC25A67-7008-49CC-BA80-357918A237EA wds:Q51076389-FF4D23F7-F4DA-491B-B1D9-09A6120EAE18 wds:Q51076389-FFF63F6F-13ED-4198-ADAF-9A6734F7F990 wds:Q51076389-DE06AFE9-88BC-4794-A03E-4458B74BCCB7 wds:Q51076389-E29ABEFD-0BDC-4962-BC7B-17A700D8E5D9 wds:Q51076389-C44C2ED5-2817-4841-B875-CDA99787B745 wds:Q51076389-DDE917D8-2C40-47F6-AA0D-653752921109 wds:Q51076389-8C13AC90-B19B-491F-A3A0-BAF46373631E wds:Q51076389-8F1DC5FD-6D53-4C72-9CAC-9B7521EC3566 wds:Q51076389-AD844878-92AD-482F-8583-59D36D71871A wds:Q51076389-7EA6DBA5-13AC-412C-8E6F-B7D977F4D194 wds:Q51076389-8444F60C-5E51-4BA9-BED8-920F8D90BEA2 wds:Q51076389-74FA3462-2CEB-42B1-A5E6-F882A6EC0B55 wds:Q51076389-77FD2D3C-38C6-46E5-A213-E1CFADAE6C07 wds:Q51076389-57CB3C73-1ACC-4F7D-AF91-A30F96506E1F wds:Q51076389-5E7D3E13-E872-477D-8B68-A829749370D7 wds:Q51076389-5EAFB5A8-4B9A-4A7B-9538-8E2C6EBB9876 wds:Q51076389-34BD5DDB-D2EE-4B9A-B8FF-66F8B720874A wds:Q51076389-38D55C48-BCDE-4EC7-BB05-25DA0EC336AA
wdt:P2860
wd:Q47805171 wd:Q73292547 wd:Q33939087 wd:Q50519343 wd:Q29615125 wd:Q51330296 wd:Q67921626 wd:Q34639244 wd:Q28324515 wd:Q36633267 wd:Q34597139 wd:Q37342445 wd:Q27860872 wd:Q77803816 wd:Q33403087 wd:Q73337081 wd:Q50793569 wd:Q39703125 wd:Q72296676 wd:Q43270613 wd:Q57214940
p:P2093
wds:Q51076389-AF629673-6582-4C3F-98A6-A1F41C1C1A03 wds:Q51076389-E7751BBC-79C1-4555-BEF2-55872B9C82ED wds:Q51076389-0ABACC48-FBEB-4882-AF40-F6768515EED4 wds:Q51076389-64C8392C-EAFB-4697-B985-D87B0FF9C810 wds:Q51076389-FC465F42-A6A9-4A40-8B99-4D23E4447E39
wdt:P2093
Soo-Kon Lee Min-Chan Park Jin Su Park Sang-Won Lee Yong-Beom Park
rdfs:label
Concurrent use of methotrexate and celecoxib increases risk of silent liver fibrosis in rheumatoid arthritis patients with subclinical reduced kidney function. Concurrent use of methotrexate and celecoxib increases risk of silent liver fibrosis in rheumatoid arthritis patients with subclinical reduced kidney function.
skos:prefLabel
Concurrent use of methotrexate and celecoxib increases risk of silent liver fibrosis in rheumatoid arthritis patients with subclinical reduced kidney function. Concurrent use of methotrexate and celecoxib increases risk of silent liver fibrosis in rheumatoid arthritis patients with subclinical reduced kidney function.
schema:name
Concurrent use of methotrexate and celecoxib increases risk of silent liver fibrosis in rheumatoid arthritis patients with subclinical reduced kidney function. Concurrent use of methotrexate and celecoxib increases risk of silent liver fibrosis in rheumatoid arthritis patients with subclinical reduced kidney function.
p:P1476
wds:Q51076389-E9861168-5312-4F13-BA03-80163D4B22CD
wdt:P1476
Concurrent use of methotrexate and celecoxib increases risk of silent liver fibrosis in rheumatoid arthritis patients with subclinical reduced kidney function.
p:P304
wds:Q51076389-1389A0FF-4459-4CF1-9E17-1CE8EA30B249
wdt:P304
1415-1423
p:P31
wds:Q51076389-3DD9B659-9824-4A6C-8367-5B4E2271A2CA
wdt:P31
wd:Q13442814
p:P921
wds:Q51076389-C8247601-44BB-4A03-84C1-36CA78C9F3A5 wds:Q51076389-A7BE6F9B-1952-4B37-9107-3AA28E7E6560
wdt:P921
wd:Q187255 wd:Q422232
p:P698
wds:Q51076389-1D47064A-D8F1-4384-B8DF-07817398D822
wdtn:P698
n9:24941927
wdt:P698
24941927
p:P1433
wds:Q51076389-803FFAFF-F663-4FB2-83A3-25E91D92EFBB
wdt:P1433
wd:Q15754927
p:P433
wds:Q51076389-5030CFFA-5191-4745-8943-3B6EE0248E6A
p:P478
wds:Q51076389-7E8F8BC4-7A6D-4FE9-9ADD-9C4591ED8FAF
wdt:P433
10
wdt:P478
33
p:P356
wds:Q51076389-2810DE45-7881-4D08-97CC-CF33A0D94237
wdtn:P356
n8:S10067-014-2719-7
wdt:P356
10.1007/S10067-014-2719-7